Oligonucleotide Synthesis Market Will Reach USD 2.9 Billion by 2024: Meticulous Research®

A report into the projected growth of the current point of care diagnostics market by Meticulous Research® has produced some incredible forecasts for the industry. By 2024, it’s expected to have grown at a CAGR of 10.5%, reaching $2.9 billion.

Pune, India - May 10, 2019 /MarketersMedia/ —

Oligonucleotide synthesis market has shown strong growth pattern in recent year’s majorly due to growing adoption of synthesized oligonucleotides in diagnostic and clinical applications, rising R&D expenditure and government investment in pharmaceutical and biotechnology companies, plummeting cost of sequencing, increasing public & private spending on genomics, and rising venture capital investments/funding. However, factors such as lack of regulations for therapeutic oligos and price erosion of synthesized oligonucleotides are likely to hinder the market growth to some extent.

Meticulous Research® in its latest publication on oligonucleotide synthesis market states that the global oligonucleotide synthesis market will increase at a CAGR of 10.5% from 2019 to 2024 to reach USD 2.9 Billion by 2024. Wherein, geographically, North America commanded the largest share in this market followed by Europe. The major share of North America is mainly attributed to substantial growth in R&D investment; better accessibility & higher adoption of technically advanced products; and the presence of significantly improved infrastructure in biotechnology sector.

Download Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=4953

The report provides meticulous analysis of global oligonucleotide synthesis market by segmenting it on the basis of product (synthesized oligonucleotide, reagents/consumables, and equipment), application (research, diagnostics, therapeutics), and end user (academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories others). Wherein, among products, synthesized oligonucleotide segment commanded the largest share in this market. The largest share of this segment is primarily attributed to increased adoption and application of synthesized oligonucleotides in research, diagnostics, and therapeutics.

The key players analyzed in the global oligonucleotide synthesis market are Danaher Corporation (U.S.), Merck KGaA (Germany), Eurofins Scientific SE (Europe), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies (U.S.), GE Healthcare (U.S.), GeneDesign, Inc. (Japan), Kaneka Eurogentec S.A. (Belgium), LGC Biosearch Technologies (U.S.), Bio-synthesis Inc. (U.S.), TriLink BioTechnologies, LLC (U.S.), and ATD Bio Ltd. (U.K.)

Check Discount of Oligonucleotide Synthesis Market - Global Opportunity Analysis and Industry Forecast (2019-2024)

Key Topics Covered in This Report:
1. Introduction

2. Research Methodology
2.1. Research Pocesss
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Growing Adoption of Synthesized Oligonucleotides in Diagnostics and
Clinical Applications
4.2.1.2. Rising R&D Expenditure and Government Investment in Pharmaceutical
and Biotechnology Companies
4.2.1.3. Plummeting Cost of Sequencing
4.2.1.4. Increasing Public-Private Spending on Genomics
4.2.1.5. Rising Venture Capital Investments/Funding
4.2.2. Restraints
4.2.2.1. Lack of Regulations for Therapeutic Oligos
4.2.2.2. Price Erosion of Synthesized Oligonucleotides
4.2.3. Opportunities
4.2.3.1. Emerging Asian Markets
4.2.3.2. Therapeutic Oligos
4.2.4. Challenges
4.2.4.1. Large-Scale Synthesis of Oligonucleotides
4.2.4.2. Delivery of Oligonucleotide Drugs to Specific Targets

5. Oligonucleotide Synthesis Market, by Product
5.1. Introduction
5.2. Synthesized Oligonucleotides
5.2.1. By Product
5.2.1.1. Primers
5.2.1.2. Probes
5.2.1.3. Large-Scale Synthesis Oligonucleotides
5.2.1.4. Intermediate-Scale Synthesis Oligonucleotides
5.2.1.5. Linkers & Adaptors
5.2.2. By Type
5.2.2.1. Custom Oligonucleotides
5.2.2.2. Pre-Designed Oligonucleotides
5.3. Reagents/Consumables
5.4. Equipment

6. Oligonucleotide Synthesis Market, by Application
6.1. Introduction
6.2. Research
6.2.1. PCR
6.2.2. qPCR/RTqPCR
6.2.3. Sequencing
6.2.4. Gene Synthesis
6.2.5. Other Research Applications
6.3. Diagnostics
6.4. Therapeutics
6.4.1. RNAi
6.4.2. Nucleic Acid Aptamers
6.4.3. DNA/Antisense Oligonucleotides
6.4.4. Immunotherapy Applications

7. Oligonucleotide Synthesis Market, by End User
7.1. Introduction
7.2. Academic Research Institutes
7.3. Pharmaceutical and Biotechnology Companies
7.4. Diagnostic Laboratories
7.5. Others

8. Oligonucleotide Synthesis Market, by Geography
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. U.K.
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. Japan
8.3.2. China
8.3.3. India
8.3.4. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Latin America
8.4.2. Middle East & Africa

9. Competitive Landscape
9.1. Competitive Benchmarking
9.2. Market Share Analysis

10. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Danaher Corporation
10.2. Merck KGaA (Sigma-Aldrich Co. LLC)
10.3. Eurofins Genomics LLC (Part of Eurofins Scientific SE)
10.4. Thermo Fisher Scientific, Inc.
10.5. Agilent Technologies, Inc.
10.6. GE Healthcare
10.7. GeneDesign Inc. (Part of Ajinomoto Co., Inc.)
10.8. Kaneka Eurogentec S.A. (Part of Kaneka Corporation)
10.9. LGC Biosearch Technologies
10.10. Bio-synthesis Inc.
10.11. TriLink Biotechnologies LLC (Part of Maravai Lifesciences)
10.12. ATDBio Ltd.

11. Appendix
11.1. Questionnaire
11.2. Available Customization

Request TOC and Sample Pages @ https://www.meticulousresearch.com/request-sample-report/cp_id=4953

About Meticulous Research®
Meticulous Research® is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Pune, India
Phone: +91 744-7780008
Website: https://www.meticulousresearch.com/product/Oligonucleotide-Synthesis-Market-4953

Source URL: https://marketersmedia.com/oligonucleotide-synthesis-market-will-reach-usd-29-billion-by-2024-meticulous-research/510944

Source: MarketersMedia

Release ID: 510944